Skip to main content
Toggle navigation
Login
Search
Home
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
D
Dang, Xibei
PumasAI
(
S-108
)
Impact of Misspecified Residual Error Model for Heavy-Tailed Error Distribution on PK Model Parameter Estimates
Xibei Dang
Favorite
Das, Sharmistha
Vertex Pharmaceuticals Incorporated
(
T-027
)
Drug-drug interactions while breastfeeding with mother/infant medications: What's safe?
Sharmistha Das
Favorite
de Witte, Wilhelmus
ESQlabs GmbH
(
M-048
)
Development of a whole-body physiologically-based pharmacokinetic (PBPK) model for large molecule FcRn inhibitors in pregnancy incorporating placental transfer
Wilhelmus de Witte
Favorite
(
T-004
)
Continuous infusion simulations in PBPK and QSP models reveal steady-state properties and rate-limiting steps.
Wilhelmus de Witte
Favorite
Desai, Devam
Center of Pharmacometrics and Systems Pharmacology, University of Florida, Orlando, FL
(
T-005
)
Bench to bedside modelling of mRNA encoding IgG using a multiscale mechanistic PK-PD model: A case study with anti-claudin 18.2
Devam Desai
Favorite
(
T-006
)
Translational two-pore PBPK model to characterize whole-body disposition of different-size oligonucleotide therapeutics
Devam Desai
Favorite
Dhakal, Saroj
Sanofi
(
T-106
)
DDIapp - A web-based application for static drug-drug interaction risk assessment.
Saroj Dhakal
Favorite
Dogra, Prashant
Houston Methodist Research Institute
(
T-075
)
Mechanistic Modeling and Unsupervised Learning Reveal Drivers of Inter-Individual Variability in COVID-19 Vaccine-Induced Immunity
Prashant Dogra
Favorite
Dombrowsky, Erin
Bristol Myers Squibb
(
S-007
)
Understanding the Utilization of SDTM and ADaM Datasets in Pharmacometric Programming
Erin Dombrowsky
Favorite
Dong, Min
Johnson & Johnson Innovative Medicine
(
M-088
)
PK/PD Analysis of the Primary Endpoint for Nipocalimab in Sjögren's Disease
Min Dong
Favorite
Du, lihong
Merck & Co., Inc.,
(
T-059
)
Characterizing the Exposure–Response Relationship of MK-2060 in Participants with End Stage Kidney Disease Receiving Hemodialysis
lihong Du
Favorite
Dumbleton, Jacob
A2-Ai, USA
(
M-067
)
reportifyr: an R-based Open-Source Tool for Automated Reporting
Jacob Dumbleton
Favorite
Dunbar, Alexandra
University of Colorado Anschutz Medical Campus
(
T-107
)
Use of Emtricitabine-Triphosphate Concentrations in Dried Blood Spots to Evaluate Pre-Exposure Prophylaxis (PrEP) Adherence
Alexandra Dunbar
Favorite
